France's national cancer agency, which steers the national cancer strategy and funds and labels research, trial networks and early-phase units.
Created by the 2004 public health law as the operational arm of the first Plan Cancer, INCa is a public interest group under the health and research ministries. It coordinates the ten-year national cancer strategy, funds research through calls such as PAIR and PHRC-K, labels the SIRIC integrated research sites and the CLIP² early-phase trial network, and ran the AcSé programme that gave patients access to targeted drugs outside their approved indication based on molecular profile. It publishes national guidelines, screening programmes and cancer statistics with Santé publique France.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to Institut National du Cancer, including child institutions. 32 works · 240 citations · 72% open access · 9% clinical trials · 0% reviews.
Director General of the Institut National du Cancer, responsible for running France's national cancer agency since October 2024.
Oncology professor and Inserm team leader who directs the Institut du Cancer Paris CARPEM, the OECI-accredited comprehensive cancer centre of AP-HP Centre in Paris.
Breast medical oncologist from Gustave Roussy who chairs the board of France's Institut National du Cancer.
Shares Institut Curie, Gustave Roussy, UNICANCER, Funding follows fashion, not burden.
Shares UNICANCER, Tumour-agnostic (tissue-agnostic) approval, Basket, umbrella, and platform trials, Trials enrol too few, too slowly.
Shares Institut Curie, UNICANCER.
Shares Gustave Roussy, Basket, umbrella, and platform trials, Trials enrol too few, too slowly.
Shares Institut Curie, Gustave Roussy, UNICANCER.
Shares International Agency for Research on Cancer (IARC / WHO), Funding follows fashion, not burden.
Shares Basket, umbrella, and platform trials, Trials enrol too few, too slowly.